Black Diamond Therapeutics, Inc. (NASDAQ:BDTX – Get Free Report) was the recipient of a large growth in short interest in the month of September. As of September 30th, there was short interest totalling 6,910,000 shares, a growth of 17.9% from the September 15th total of 5,860,000 shares. Based on…
